| FORM 3 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 | | OMB APPROVAL | | OMB Number: | 3235-0104 | | Expires: | February 28, 2011 | | Estimated average burden | | hours per response | 0.5 |
|
|
1. Name and Address of Reporting Person*
(Street)
| 2. Date of Event Requiring Statement (Month/Day/Year)
10/15/2009 | 3. Issuer Name and Ticker or Trading Symbol
ABBOTT LABORATORIES
[ABT]
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable) | Director | | 10% Owner | | X | Officer (give title below) | | Other (specify below) | | Senior Vice President |
| 5. If Amendment, Date of Original Filed (Month/Day/Year)
|
6. Individual or Joint/Group Filing (Check Applicable Line)
| X | Form filed by One Reporting Person | | Form filed by More than One Reporting Person |
|
| Table I - Non-Derivative Securities Beneficially Owned |
|---|
| 1. Title of Security (Instr.
4)
| 2.
Amount of Securities Owned (Instr.
4)
| 3. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)
| 4. Nature of Indirect Beneficial Ownership (Instr.
5)
|
|---|
|
Common shares without par value
|
26,107
|
D
| |
|
Common shares without par value
|
627
|
I
|
Profit Sharing Trust (US)
|
|
Common shares without par value
|
128
|
I
|
Profit Sharing Trust (Puerto Rico)
|
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities) |
|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year)
| 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Excercise Price of Derivative Security
| 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)
| 6. Nature of Indirect Beneficial Ownership (Instr. 5)
|
|---|
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
|---|
|
Option (right to buy)
| 02/15/2004 | 02/14/2012 |
Common shares
|
336
|
$
53.625
|
D
| |
|
Option (right to buy)
| 02/15/2005 | 02/14/2012 |
Common shares
|
1,596
|
$
53.625
|
D
| |
|
Option (right to buy)
| 02/15/2003 | 02/14/2012 |
Common shares
|
1,596
|
$
53.625
|
D
| |
|
Option (right to buy)
| 02/15/2004 | 02/14/2012 |
Common shares
|
1,259
|
$
53.625
|
D
| |
|
Option (right to buy)
| 02/18/2006 | 02/17/2015 |
Common shares
|
1
|
$
46.34
|
D
| |
|
Option (right to buy)
| 02/18/2007 | 02/17/2015 |
Common shares
|
443
|
$
46.34
|
D
| |
|
Option (right to buy)
| 02/18/2008 | 02/17/2015 |
Common shares
|
2,157
|
$
46.34
|
D
| |
|
Option (right to buy)
| 02/18/2006 | 02/17/2015 |
Common shares
|
3,299
|
$
46.34
|
D
| |
|
Option (right to buy)
| 02/18/2007 | 02/17/2015 |
Common shares
|
2,857
|
$
46.34
|
D
| |
|
Option (right to buy)
| 02/18/2008 | 02/17/2015 |
Common shares
|
1,143
|
$
46.34
|
D
| |
|
Option (right to buy)
| 09/09/2005 | 02/10/2010 |
Common shares
|
792
|
$
46.65
|
D
| |
|
Option (right to buy)
| 02/17/2007 | 02/16/2016 |
Common shares
|
1,734
|
$
44.16
|
D
| |
|
Option (right to buy)
| 02/17/2008 | 02/16/2016 |
Common shares
|
1,733
|
$
44.16
|
D
| |
|
Option (right to buy)
| 02/17/2009 | 02/16/2016 |
Common shares
|
1,733
|
$
44.16
|
D
| |
|
Option (right to buy)
| 04/24/2007 | 04/23/2016 |
Common shares
|
10,267
|
$
41.48
|
D
| |
|
Option (right to buy)
| 04/24/2008 | 04/23/2016 |
Common shares
|
10,266
|
$
41.48
|
D
| |
|
Option (right to buy)
| 04/24/2009 | 04/23/2016 |
Common shares
|
10,267
|
$
41.48
|
D
| |
|
Option (right to buy)
| 02/16/2010 | 02/15/2017 |
Common shares
|
11,900
|
$
52.54
|
D
| |
|
Option (right to buy)
| 02/15/2010 | 02/14/2018 |
Common shares
|
11,300
|
$
55.56
|
D
| |
|
Option (right to buy)
| 08/05/2009 | 02/08/2011 |
Common shares
|
697
|
$
56.98
|
D
| |
|
Option (right to buy)
| 08/05/2009 | 02/19/2014 |
Common shares
|
1,918
|
$
56.98
|
D
| |
|
Option (right to buy)
| 08/05/2009 | 02/13/2013 |
Common shares
|
1,538
|
$
56.98
|
D
| |
|
Option (right to buy)
| 08/05/2009 | 02/08/2011 |
Common shares
|
2,162
|
$
56.98
|
D
| |
|
Option (right to buy)
| 05/15/2009 | 02/08/2011 |
Common shares
|
1,602
|
$
57.14
|
D
| |
|
Option (right to buy)
| 05/05/2009 | 02/19/2014 |
Common shares
|
1,331
|
$
56
|
D
| |
|
Option (right to buy)
| 03/19/2009 | 02/19/2014 |
Common shares
|
1,198
|
$
57.25
|
D
| |
|
Option (right to buy)
| 03/09/2009 | 02/10/2010 |
Common shares
|
1,730
|
$
57.01
|
D
| |
|
Option (right to buy)
| 11/10/2008 | 02/10/2010 |
Common shares
|
1,001
|
$
51.28
|
D
| |
|
Option (right to buy)
| 11/10/2008 | 02/13/2013 |
Common shares
|
2,834
|
$
51.28
|
D
| |
|
Option (right to buy)
| 02/15/2011 | 02/14/2018 |
Common shares
|
11,300
|
$
55.56
|
D
| |
| Explanation of Responses: |
|
|
|
Remarks:
|
| John A. Berry, by power of attorney for Carlos Alban | 10/19/2009 |
| ** Signature of Reporting Person | Date |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
| * If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see Instruction 6 for procedure. |
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |
Exhibit 24.1
POWER OF ATTORNEY
The undersigned constitutes and appoints LAURA J.
SCHUMACHER, JOHN A. BERRY, RICHARD E. GREEN and STEVEN L.
SCROGHAM, and each of them individually, as the undersigned's
true and lawful attorney-in-fact and agent, with full power of
substitution and resubstitution, for the undersigned and in the
undersigned's name, place and stead, to prepare and sign any and
all Securities and Exchange Commission ("SEC") Notices of
Proposed Sales of Securities pursuant to Rule 144 under the
Securities Act of 1933 on Form 144, all SEC statements on Forms
3, 4 and 5 as required under Section 16(a) of the Securities
Exchange Act of 1934, and any amendments to such forms, and to
file the same with all exhibits thereto, and other documents in
connection therewith, with the SEC, granting unto said attorney-
in-fact and agent full power and authority to do and perform each
act and thing requisite and necessary to be done under said Rule
144 and Section 16(a), as fully for all intents and purposes as
the undersigned might or could do in person, hereby ratifying and
confirming all that said attorney-in-fact and agent may lawfully
do or cause to be done by virtue hereof.
A copy of this power of attorney shall be filed with the
SEC. The authorization set forth above shall continue in full
force and effect until the undersigned is no longer required to
file Forms 144, 3, 4, or 5 or if earlier, until the undersigned
revokes such authorization by written instructions to the
attorney-in-fact.
Date: October 15, 2009
/s/ Carlos Alban
Signature of Reporting Person
Carlos Alban
Name
Abbott Laboratories
100 Abbott Park Road
Abbott Park, IL 60064